Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

10.1016/j.clinthera.2013.02.007

Saved in:
Bibliographic Details
Main Authors: Peveling-Oberhag, J., Zeuzem, S., Yong, W.P., Kunz, T., Paquet, T., Bouillaud, E., Urva, S., Anak, O., Sellami, D., Kobalava, Z.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2014
Subjects:
Healthy subjects
Hepatic impairment
Molecular therapeutics
Pharmacokinetics
Online Access:http://scholarbank.nus.edu.sg/handle/10635/116996
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1016/j.clinthera.2013.02.007

Similar Items